ALLEGRA ADS MADE FALSE SUPERIORITY CLAIMS, DDMAC SAYS

Washington Drug Letter
KEYWORDS Advertising / FDA / Warning
A A

Print and television ads for Aventis Pharmaceuticals’ leading allergy product made unsubstantiated superiority claims to other prescription remedies on the market, according to an untitled letter released by the FDA, which caused the firm to pull the ads in response, Aventis announced Jan. 14.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00